InterMune is now a wholly-owned subsidiary of Roche. For additional information on the product Esbriet®, patients and health care providers should visit www.Gene.com and www.Roche.com.


You are now leaving the InterMune website. If you would like to continue, click Continue. Otherwise, click Cancel.
CancelContinue